Maca (Lepidium meyenii) is an adaptogenic root vegetable native to the high altitudes of the Peruvian Andes. Traditionally cultivated for both nutritional and medicinal purposes, it is widely used as a supplement to enhance libido, increase subjective energy, and support hormonal transition symptoms.
Unlike many botanical aphrodisiacs marketed as "testosterone boosters," Maca operates primarily through central nervous system modulation and endocannabinoid pathways. Clinical trials consistently show that its effects on sexual function and mood occur independently of changes to serum testosterone or estrogen levels.

Maca is most renowned for its aphrodisiac properties. Multiple randomized controlled trials have demonstrated that Maca supplementation improves subjective perception of sexual desire and well-being in both men and women. In men with mild erectile dysfunction, Maca extracts (2,400 mg/day) led to significant increases in the International Index of Erectile Function (IIEF-5) scores compared to placebo [3]. In postmenopausal women, doses of 3.5 g/day reduced measures of sexual dysfunction and psychological distress, completely independent of estrogenic or androgenic activity [4].
As an adaptogen, Maca is often used to combat fatigue and improve endurance. A pilot investigation in trained male cyclists showed that 14 days of Maca extract supplementation significantly improved 40 km cycling time trial performance and self-rated sexual desire compared to baseline [5]. While not a direct stimulant like caffeine, users report sustained subjective energy increases.
Maca has been shown to alleviate psychological symptoms associated with menopause and late-onset hypogonadism. In a 12-week study on middle-aged men with late-onset hypogonadism symptoms, 1.6 g of Maca extract daily significantly improved the Aging Males' Symptoms (AMS) psychological and somatic scores [6]. Similarly, it has been shown to reduce anxiety and depression metrics in postmenopausal women without altering serum follicle-stimulating hormone (FSH) or estradiol [4:1].
The bioactivity of Maca is largely attributed to its unique secondary metabolites: macamides and macaenes.
| Outcome | Evidence Quality | Effect Size | Clinical Notes | Sources |
|---|---|---|---|---|
| Sexual Desire / Libido | High | Moderate | Consistently improved across genders in double-blind trials; effects seen after 2-6 weeks. Independent of testosterone/estrogen levels. | [3:2][4:3][5:1] |
| Erectile Function | Moderate | Small to Moderate | Demonstrated small but significant improvements in men with mild ED (IIEF-5 scores) over 12 weeks. | [3:3] |
| Menopausal Mood Symptoms | Moderate | Moderate | Reduced anxiety, depression, and psychological stress in postmenopausal women. | [4:4] |
| Male Hypogonadism Symptoms | Moderate | Moderate | Reduced Aging Males' Symptoms (AMS) scores, including somatic and psychological subscales over 12 weeks. | [6:2] |
| Physical Endurance | Low | Small | Pilot data showed improved cycling time trial performance in trained athletes after 14 days. Larger trials needed. | [5:2] |
| Semen Quality (Motility/Count) | Low | Small to Moderate | Some preliminary trials suggest improvements in sperm count and motility (often associated with Black Maca), though meta-analyses deem the evidence limited and of low certainty. | [2:3] |
While Maca is a widely consumed food crop with a high safety ceiling, high-dose supplementation carries specific considerations:
Shin, D., Jeon, S. H., Piao, J., Park, H. J., Tian, W. J., Moon, D. G., Ahn, S. T., Jeon, K.-H., Zhu, G. Q., & Park, I. (2023). Efficacy and Safety of Maca (Lepidium meyenii) in Patients with Symptoms of Late-Onset Hypogonadism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. The World Journal of Men's Health. https://pubmed.ncbi.nlm.nih.gov/36593713/ ↩︎
Villar-López, M., et al. (2024). Exploring the chemical and pharmacological variability of Lepidium meyenii: a comprehensive review of the effects of maca. Frontiers in Pharmacology. https://pmc.ncbi.nlm.nih.gov/articles/PMC10910417/ ↩︎ ↩︎ ↩︎ ↩︎
Zenico, T., Cicero, A. F. G., Valmorri, L., Mercuriali, M., & Bercovich, E. (2009). Subjective effects of Lepidium meyenii (Maca) extract on well-being and sexual performances in patients with mild erectile dysfunction: a randomised, double-blind clinical trial. Andrologia. https://pubmed.ncbi.nlm.nih.gov/19260845/ ↩︎ ↩︎ ↩︎ ↩︎
Brooks, N. A., Wilcox, G., Walker, K. Z., Ashton, J. F., Cox, M. B., & Stojanovska, L. (2008). Beneficial effects of Lepidium meyenii (Maca) on psychological symptoms and measures of sexual dysfunction in postmenopausal women are not related to estrogen or androgen content. Menopause (New York, N.Y.). https://pubmed.ncbi.nlm.nih.gov/18784609/ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Stone, M., Ibarra, A., Roller, M., Zangara, A., & Stevenson, E. (2009). A pilot investigation into the effect of maca supplementation on physical activity and sexual desire in sportsmen. Journal of Ethnopharmacology. https://pubmed.ncbi.nlm.nih.gov/19781622/ ↩︎ ↩︎ ↩︎
Shin, D., et al. (2023). Efficacy and Safety of Maca (Lepidium meyenii) in Patients with Symptoms of Late-Onset Hypogonadism: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. The world journal of men's health. https://doi.org/10.5534/wjmh.220112 ↩︎ ↩︎ ↩︎